MSN - Profile
✉ Email this page to a colleague
Drugs and US Patents for MSN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msn | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 214366-002 | May 10, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | BUMETANIDE | bumetanide | INJECTABLE;INJECTION | 215364-001 | Aug 4, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 208037-002 | Sep 9, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | PREGABALIN | pregabalin | TABLET, EXTENDED RELEASE;ORAL | 213226-001 | Apr 13, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |